Articles

International Journal of Drug Discovery and Pharmacology

Open AccessCommunication

Strategizing Cardiovascular Management in Diabetic Patients: Insights and Advancements from the 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Hongyuan Zhang, Darren Green, Yanrong Liu

2025, 4(1): 100002. doi: 10.53941/ijddp.2025.100002

Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4+Foxp3+ Regulatory T Cell Immunosuppression

Ying Shao, William Y. Yang, Gayani Nanayakkara, Fatma Saaoud, Mohammed Ben Issa, Keman Xu, Yifan Liu, Xiaohua Jiang, Sadia Mohsin, Hong Wang, Xiaofeng Yang

2024, 3(4): 100022. doi: 10.53941/ijddp.2024.100022

Metabolomics in Cardiovascular Diseases

Shan Lu, Zisheng Huang, Baitao Liu, Yan Zhang

2024, 3(4): 100019. doi: 10.53941/ijddp.2024.100019

Integrins as Drug Targets in Vascular and Related Diseases

Emily Meredith, Martin A. Schwartz

2024, 3(2): 100010. doi: 10.53941/ijddp.2024.100010

A Minimally Invasive Approach for Cardiac Electrophysiology Studies in Mice

Min Zi, Sabu Abraham, Alicia D'souza, David Hutchings, Sukhpal Prehar, Xin Wang, Elizabeth J Cartwright

2023, 2(1): 72-84. doi: 10.53941/ijddp.0201006

The Therapeutic Effects of Ligustrazine in Combination with Other Drugs in Cardiovascular Diseases

Peihua Dong, Yu Huang, Yujie Pu

2023, 2(1): 11-17. doi: 10.53941/ijddp.0201005

Is miR-21 A Therapeutic Target in Cardiovascular Disease?

Antoinette Holland, Molly Enrick, Arianna Diaz, Liya Yin

2023, 2(1): 26-36. doi: 10.53941/ijddp.0201003

The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease

Honglin Xu, Dingwei Wang, Chiara Ramponi, Xin Wang, Hongyuan Zhang

2022, 1(1): 5. doi: 10.53941/ijddp.v1i1.179

Cardiac β-Adrenoceptor Signaling: The New Insight on An Old Target in the Therapy of Cardiovascular Disease

Ying Song, Anthony Yiu-Ho WOO, Yan Zhang, Ruiping Xiao

2022, 1(1): 3. doi: 10.53941/ijddp.v1i1.177

Total 9Go to